Supplies of high-demand obesity treatments are improving, but that doesn’t mean it's easier to get them. Many employers and ...

This will be a “pivotal year,” one expert says, for GLP-1 drugs, which are massively disrupting the benefits landscape.

The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the ...

Eli Lilly says new research shows its medication Zepbound helped patients shed more weight over a shorter period of time than Novo Nordisk’s Wegovy. The Biden administration has proposed a new rule to ...

Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...

Tori Allen says she’s thrilled to have lost 80 pounds since she went on Wegovy, one of the GLP-1 drugs that more and more people are using to treat diabetes or lose weight. But slimming down ...

Last year was a pivotal year for the pharmaceutical industry. Under the IRA’s Medicare Drug Price Negotiation Program (the ...

If the CMS rule to cover obesity medications is finalized, coverage will increase by other insurers, experts predicted. HHS ...

Commissions do not affect our editors' opinions or evaluations. If you’re considering enrolling in a Medicare Advantage plan (also known as Medicare Part C) in California to meet your health ...

Commissions do not affect our editors' opinions or evaluations. Aetna Medicare Advantage offers a wide range of Medicare health care plans and a variety of additional benefits aimed toward further ...